1. Home
  2. CRBU vs GMHS Comparison

CRBU vs GMHS Comparison

Compare CRBU & GMHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • GMHS
  • Stock Information
  • Founded
  • CRBU 2011
  • GMHS N/A
  • Country
  • CRBU United States
  • GMHS China
  • Employees
  • CRBU N/A
  • GMHS N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • GMHS
  • Sector
  • CRBU Health Care
  • GMHS
  • Exchange
  • CRBU Nasdaq
  • GMHS NYSE
  • Market Cap
  • CRBU 93.0M
  • GMHS 106.1M
  • IPO Year
  • CRBU 2021
  • GMHS N/A
  • Fundamental
  • Price
  • CRBU $1.02
  • GMHS $1.76
  • Analyst Decision
  • CRBU Strong Buy
  • GMHS
  • Analyst Count
  • CRBU 4
  • GMHS 0
  • Target Price
  • CRBU $8.50
  • GMHS N/A
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • GMHS 18.0K
  • Earning Date
  • CRBU 05-08-2025
  • GMHS 01-01-0001
  • Dividend Yield
  • CRBU N/A
  • GMHS N/A
  • EPS Growth
  • CRBU N/A
  • GMHS N/A
  • EPS
  • CRBU N/A
  • GMHS 0.03
  • Revenue
  • CRBU $9,918,000.00
  • GMHS $119,023,021.00
  • Revenue This Year
  • CRBU N/A
  • GMHS N/A
  • Revenue Next Year
  • CRBU $161.81
  • GMHS N/A
  • P/E Ratio
  • CRBU N/A
  • GMHS $61.53
  • Revenue Growth
  • CRBU N/A
  • GMHS N/A
  • 52 Week Low
  • CRBU $0.66
  • GMHS $0.96
  • 52 Week High
  • CRBU $3.00
  • GMHS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 57.50
  • GMHS N/A
  • Support Level
  • CRBU $0.98
  • GMHS N/A
  • Resistance Level
  • CRBU $1.21
  • GMHS N/A
  • Average True Range (ATR)
  • CRBU 0.10
  • GMHS 0.00
  • MACD
  • CRBU 0.02
  • GMHS 0.00
  • Stochastic Oscillator
  • CRBU 68.23
  • GMHS 0.00

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About GMHS GAMEHAUS HOLDINGS INC

Gamehaus Holdings Inc is a technology-driven mobile game publishing company for small- and medium-sized game developers. It built a diverse game portfolio across multiple genres, including social casino, match, simulation, RPG, puzzle, and bingo, others, and distributes mobile games created by developer partners across a wide range of gaming markets, including in countries such as the U.S., the U.K., Australia, Germany, France, Canada, Brazil, Japan, and India, among others. The company offers a comprehensive package of services covering all aspects of the game life cycle, including (i) game development, (ii) screening and pre-publication testing, (iii) user acquisition, and (iv) monetization.

Share on Social Networks: